Site Search

... little or nothing to do the right thing. In most cases, these solutions will save the state millions and perhaps billions of dollars through health care cost reductions and increased worker productivity. So, how does your state measure up? Download the report     2013 How Do You Measure Up ...

... research Increase funding for Every Woman's Life program (provides breast and cervical cancer screenings for uninsured women) Expand access to health-care to Virginians who fall in the coverage-gap Simply the process for cancer patients who are seeking an exception from step-therapy 2018 State ...

... has made life harder for many New Jerseyans.  They don't need their insurance carrier to make them jump through hoops before they can get the care their doctor prescribes. @NJSenatePres and @NelliePou must support S3051 and #ReformStepNJ. The practice of step therapy has grown ... to a vote. Reforming step therapy means ensuring that it is ✔ safe for patients ✔ clinically grounded, and ✔ transparent to patients and health care providers. #ReformStepNJ We need @NJSenatePres and @NelliePou to bring S3051 to a vote. Fail first policies can result in patients not ... these plans. @NJSenatePres and @NelliePou must pass S3051 #ReformStepNJ In an analysis of coverage decisions for 17 of the 20 largest commercial health insurers in the U.S., it was found that ALL insurers used step therapy to restrict access to drugs, ranging from 2% to 49% of coverage ...

... received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect and treat cancer, but these staggering incidence and mortality rates suggest that many New Yorkers aren’t ... increasingly important for the treatment of other diseases, including arthritis, other autoimmune conditions and rare diseases. Currently, many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker testing for all patients who could benefit, ... tested for certain guideline-indicated biomarkers. With biomarker testing increasingly becoming a standard of care in oncology, it’s time that health insurance plans keep up with innovations in testing and treatment. Improving access to biomarker is a simple way for legislators in Albany ...